Latest News about MRK
Recent news which mentions MRK
From Benzinga
From InvestorPlace
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
April 10, 2024
From Benzinga
From Benzinga
Why Is Moderna Stock Trading Higher On Tuesday?
April 09, 2024
From Benzinga
Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement
April 08, 2024
From InvestorPlace
Understanding Merck & Co's Position In Pharmaceuticals Industry Compared To Competitors
April 08, 2024
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
April 08, 2024
From Motley Fool
Down 75%. Is Agenus Stock a Buy on the Dip?
April 08, 2024
From Motley Fool
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
April 07, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
From Benzinga
Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data
April 04, 2024
From Benzinga
Forget Shopify: This Stock Has Made Far More Millionaires
April 03, 2024
From Motley Fool
From InvestorPlace
Japan Index Falls While Asia And Europe Markets Rise, And Gold Exceeds $2,220 - Global Markets Today While US Slept
March 28, 2024
From Benzinga
Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook
March 27, 2024
Tickers
MRK
From Benzinga
The Most Important Catalyst For Merck's Stock In 2024 Could Be Sotatercept Launch, Analyst Says
March 27, 2024
From Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
March 27, 2024
From Benzinga
From Benzinga
US Stocks Set For Rebound, Aim To Snap 3-Session Slump And Close Quarter Strong: Analyst Foresees Robust April Ahead
March 27, 2024
From Benzinga
Analysts Eye Summit Therapeutics' Ivonescimab As Potential Challenger To Merck's Keytruda in Lung Cancer Treatment
March 26, 2024
From Benzinga
After Failed Prostate Cancer Study Merck's Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study
March 21, 2024
From Benzinga
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
March 21, 2024
From Motley Fool
Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine
March 19, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.